医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world data.

广告
第一作者: Devon J,Boyne
第一单位: Oncology Outcomes Research Initiative, University of Calgary, Alberta, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Alberta, Canada; Division of Real World and Advanced Analytics, Cytel, Toronto, Canada. Electronic address: devon.boyne1@ucalgary.ca.
作者单位: Oncology Outcomes Research Initiative, University of Calgary, Alberta, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Alberta, Canada; Division of Real World and Advanced Analytics, Cytel, Toronto, Canada. Electronic address: devon.boyne1@ucalgary.ca. [1] Oncology Outcomes Research Initiative, University of Calgary, Alberta, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Alberta, Canada; Division of Real World and Advanced Analytics, Cytel, Toronto, Canada; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Alberta, Canada. [2] Division of Real World and Advanced Analytics, Cytel, Toronto, Canada. [3] Division of Real World and Advanced Analytics, Cytel, Toronto, Canada; Division of Epidemiology, Dalla Lana School of Public Health. University of Toronto. Toronto, Ontario, Canada. [4] Oncology Outcomes Research Initiative, University of Calgary, Alberta, Canada; Department of Oncology, Cumming School of Medicine, University of Calgary, Alberta, Canada; Department of Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada. [5] Departments of Epidemiology and Biostatistics, CAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA. [6]
DOI 10.1016/j.annepidem.2022.12.005
PMID 36563766
发布时间 2023-02-23
提交
  • 浏览0
Annals of epidemiology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷